We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
'Game changer' antibiotic and others in works for superbug.
- Authors
Dolgin, Elie
- Abstract
The article offers information on the drug manufacturer to produce clostridium difficile (C.difficile) as the common hospital-acquired infection in the U.S. Drug manufacturer Optimer Pharmaceuticals Inc. presents fidaxomicin as an antibiotic pill that inhibits the enzyme RNA polymerase in bacteria to effectively cut the recurrence of rate by half of the incidents. Meanwhile, French vaccine maker Sanofi Pasteur SA announces its phase 2 trial involving the preventative vaccine to prevent relapse.
- Subjects
UNITED States; DRUG factories; CLOSTRIDIOIDES difficile; NOSOCOMIAL infections; OPTIMER Pharmaceuticals Inc.; RNA polymerases; DISEASE relapse; SANOFI Pasteur SA; THERAPEUTICS
- Publication
Nature Medicine, 2011, Vol 17, Issue 1, p10
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm0111-10